Information, Expiry & Status of FDA Orange Book Patents covering Nepafenac

Appl No Product Party Prod No Patent No Patent Expiration Drug Substance Claim Drug Product Claim Patent Use Code Patent Use Description Delist Requested
21862 NEPAFENAC NOVARTIS PHARMS CORP 1 7834059 2027-01-31 U-1095 METHOD OF TREATING OCULAR INFLAMMATION
203491 NEPAFENAC NOVARTIS PHARMS CORP 1 7947295 2024-06-08 Y
203491 NEPAFENAC NOVARTIS PHARMS CORP 1 6403609 2018-07-17 Y
203491 NEPAFENAC NOVARTIS PHARMS CORP 1 9662398 2030-12-01 Y
21862 NEPAFENAC NOVARTIS PHARMS CORP 1 8071648 2025-12-02 Y
203491 NEPAFENAC NOVARTIS PHARMS CORP 1 8921337 2032-03-31 Y
21862 NEPAFENAC NOVARTIS PHARMS CORP 1 8324281 2025-12-02 Y